Zenas BioPharma, Inc. — Investor Relations & Filings
Zenas BioPharma is a clinical-stage biopharmaceutical company dedicated to the development and commercialization of transformative therapies for autoimmune diseases. The company is advancing a pipeline of immunology-based treatments to address significant unmet patient needs. Its two late-stage franchises are obexelimab and orelabrutinib. Obexelimab is an investigational bifunctional monoclonal antibody designed to suppress B cell activity by co-engaging CD19 and FcγRIIb. Orelabrutinib is an investigational, highly selective, CNS-penetrant oral small molecule BTK inhibitor. Zenas aims to become a global leader in providing innovative treatments for patients with autoimmune conditions.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| OWNERSHIP DOCUMENT | 2024-11-20 | English | |
| Major Shareholding Notification 2024 | 2024-11-12 | English | |
| 10-Q | 2024-11-12 | English | |
| FORM 8-K | 2024-11-12 | English | |
| NEA 18 VENTURE GROWTH EQUITY, L.P. -- ZENAS BIOPHARMA, INC. 13G | 2024-09-26 | English | |
| SC 13D | 2024-09-24 | English |
Browse filings by year
4 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2024
15 filings
| |||||
| 13627857 | OWNERSHIP DOCUMENT | 2024-11-20 | English | ||
| 13627859 | Major Shareholding Notification 2024 | 2024-11-12 | English | ||
| 13627907 | 10-Q | 2024-11-12 | English | ||
| 13627916 | FORM 8-K | 2024-11-12 | English | ||
| 13627920 | NEA 18 VENTURE GROWTH EQUITY, L.P. -- ZENAS BIOPHARMA, INC. 13G | 2024-09-26 | English | ||
| 13627924 | SC 13D | 2024-09-24 | English | ||
| 13627927 | SC 13D | 2024-09-24 | English | ||
| 13627932 | SC 13D | 2024-09-23 | English | ||
| 13627935 | OWNERSHIP DOCUMENT | 2024-09-21 | English | ||
| 13627938 | OWNERSHIP DOCUMENT | 2024-09-18 | English | ||
| 13627942 | Director's Dealing 2024 | 2024-09-18 | English | ||
| 13628033 | Regulatory Filings 2024 | 2024-09-18 | English | ||
| 13627945 | OWNERSHIP DOCUMENT | 2024-09-18 | English | ||
| 13627949 | OWNERSHIP DOCUMENT | 2024-09-18 | English | ||
| 13627951 | Director's Dealing 2024 | 2024-09-18 | English | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
13260917 Canada Inc.
Biotech developing oral small molecules to restore muscle s…
|
MSCL | CA | Manufacturing |
|
1608557 Ontario Inc.
Biopharmaceutical company dedicated to R&D, discovery, and …
|
OTROQ | CA | Manufacturing |
|
3B BlackBio Dx Limited
Develops molecular diagnostic kits for oncology, infectious…
|
3BBLACKBIO | IN | Manufacturing |
|
3D Medicines Inc.
Commercial-stage biopharma specializing in next-generation …
|
1244 | HK | Manufacturing |
|
3SBio Inc.
Biopharmaceutical enterprise specializing in R&D, productio…
|
1530 | KY | Manufacturing |
|
4BASEBIO PLC
Manufactures GMP-grade synthetic DNA for next-generation th…
|
4BB | GB | Manufacturing |
|
4D Molecular Therapeutics, Inc.
Develops genetic medicines using AAV vectors for ophthalmol…
|
FDMT | US | Manufacturing |
|
4Front Ventures Corp.
Vertically integrated cannabis operator managing cultivatio…
|
FFNT | CA | Manufacturing |
|
4SC AG
Biopharmaceutical company with no products under developmen…
|
VSC | DE | Manufacturing |
|
60 DEGREES PHARMACEUTICALS, INC.
Develops and commercializes medicines for infectious diseas…
|
SXTP | US | Manufacturing |
Zenas BioPharma, Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/32467/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=32467 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=32467 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=32467 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 32467}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Zenas BioPharma, Inc. (id: 32467)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.